Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07475832 · ClinicalTrials.gov registry record
Comparison of Two Biometers in Dense Cataracts
A clinical trial, sponsored by Berkeley Eye Center.
- Completed
- Registry status
- 61
- Enrollment target
NCT07475832: Completed study, sponsored by Berkeley Eye Center.
NCT07475832 is a clinical trial that has completed, run by Berkeley Eye Center. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07475832 has completed, sponsored by Berkeley Eye Center.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
This single-center, ambispective, observational study evaluates axial length acquisition in eyes with dense cataracts using the ARGOS swept-source optical coherence tomography biometer compared with the IOLMaster 700. Eligible subjects are pseudophakic adults who previously underwent complex cataract surgery because of poor visualization or poor red reflex from dense lens opacity and who had pre-operative biometry performed with both devices, with or without manual immersion A-scan ultrasonography. Enrolled subjects return for postoperative repeat biometry to confirm pre-operative measurements and to assess whether availability of an ARGOS axial length measurement may reduce the need for manual ultrasound A-scans in similar dense cataract cases. The planned sample size justification estimated that 61 patients were needed for statistical power, while 68 were originally targeted to allow for attrition in the prospective portion.
Primary Outcome
Percentage of eyes in which axial length measurements were successfully acquired using the ARGOS biometer compared with the IOLMaster 700 in eyes with dense cataracts.
Interventions
- DIAGNOSTIC_TEST IOLMaster 700
- DIAGNOSTIC_TEST ARGOS biometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2023-10-11 |
| Est. Completion | 2025-10-15 |
What the finished NCT07475832 record still lists
NCT07475832 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which IOLMaster 700 is the first listed.
NCT07475832 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07475832 about?
NCT07475832 is a clinical study titled "Comparison of Two Biometers in Dense Cataracts". This single-center, ambispective, observational study evaluates axial length acquisition in eyes with dense cataracts using the ARGOS swept-source optical coherence tomography biometer compared with the IOLMaster 700. Eligible subjects are pseudophakic adults who previously underwent complex catarac...
What is the current status of trial NCT07475832?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2023-10-11. Estimated completion is 2025-10-15.
What interventions are being tested in trial NCT07475832?
The interventions under investigation include: IOLMaster 700 (DIAGNOSTIC_TEST), ARGOS biometer (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07475832?
This trial is sponsored by Berkeley Eye Center, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI